PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Price range: £22.99 through £39.99
Buy DSIP Peptide in UAE – In Stock & Ready to Ship
DSIP (Delta Sleep-Inducing Peptide) is a widely researched peptide known for its role in sleep regulation and neuromodulation studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.
For research use only. Not intended for human or veterinary use.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied in neuroscience and endocrinology research for its role in sleep regulation, stress response modulation, and neuroendocrine signalling — making it one of the most intriguing peptides in the field of sleep biology and circadian rhythm research. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade DSIP with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC & Mass Spectrometry Verified
✅ Batch-Specific Certificate of Analysis (CoA) Included
✅ Sterile Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
DSIP is a nine-amino acid neuropeptide first isolated in 1974 from the cerebral venous blood of rabbits during slow-wave (delta) sleep — giving it its name. It was originally identified by Swiss researchers Monnier and Schoenenberger, who found that transferring blood from sleeping rabbits to waking rabbits induced sleep in the recipients, leading to the isolation and characterisation of DSIP as the active factor responsible.
Since its discovery, DSIP has been found to be widely distributed throughout the central nervous system, peripheral tissues, and various endocrine glands — suggesting a broader biological role than sleep regulation alone. Its presence across multiple biological systems has made it a relevant research tool for laboratories studying sleep-wake regulation, stress physiology, neuroendocrine interactions, and neuroprotection. Research interest in DSIP from institutions across the UAE and GCC has grown alongside expanding neuroscience and sleep biology research programmes in the region.
In controlled laboratory and pre-clinical research settings, DSIP has been studied across a range of neuroscience, endocrinology, and stress physiology applications:
Sleep Regulation Research: DSIP’s primary and most studied research application is its influence on sleep architecture — specifically slow-wave or delta sleep. Studies examine how DSIP administration affects sleep patterns, sleep stage distribution, and sleep-wake cycle parameters in pre-clinical models.
Circadian Rhythm Studies: Research has explored DSIP’s role in circadian biology, examining how this neuropeptide interacts with biological timing systems and influences the regulation of sleep-wake cycles at the cellular and systemic level.
Stress Response Modulation: Studies have investigated DSIP’s behaviour under conditions of physiological stress, examining how it influences the hypothalamic-pituitary-adrenal (HPA) axis response and stress-related hormone profiles in pre-clinical models.
Neuroendocrine Research: DSIP has been studied for its influence on multiple hormone systems — including LH, GH, cortisol, and ACTH — making it relevant to laboratories examining how neuropeptide signalling interacts with broader endocrine regulation.
Neuroprotection Studies: Research has explored DSIP’s potential neuroprotective properties in models of oxidative stress and neural injury, examining how this sleep-associated peptide influences neuronal survival and stress resistance in cellular settings.
Antioxidant Defence Research: Some studies have examined DSIP’s influence on antioxidant enzyme systems and oxidative stress markers in pre-clinical models, reflecting interest in its broader role in cellular defence mechanisms beyond sleep regulation.
Pain and Stress Tolerance Models: Research has incorporated DSIP into studies examining stress-induced analgesia and pain tolerance parameters, exploring how this neuropeptide influences the intersection of stress physiology and pain signalling.
Withdrawal and Dependency Models: Pre-clinical research has examined DSIP in models of substance dependency and withdrawal, exploring how neuropeptide modulation of stress and neuroendocrine systems influences withdrawal-associated physiological markers.
All applications listed are research-based only. DSIP is not approved for human therapeutic use.
DSIP has accumulated a distinctive and broad pre-clinical research profile since its discovery five decades ago:
The original research establishing DSIP as a sleep-modulating factor documented its ability to influence sleep architecture in rabbit models, with subsequent studies in rodent models examining its effects on delta sleep duration, sleep latency, and overall sleep-wake cycle organisation — establishing the foundational evidence for DSIP’s role in sleep biology research. Neuroendocrine research has documented DSIP’s influence on multiple pituitary hormone systems in pre-clinical models, with studies reporting effects on LH pulsatility, GH release patterns, and corticotropin-related markers — highlighting DSIP’s relevance as a multi-system neuroendocrine research tool beyond sleep biology alone. Stress physiology research has examined DSIP’s modulatory effects on HPA axis activity in animal models, with studies exploring how DSIP administration influences corticosterone levels and stress hormone dynamics under controlled stress conditions. Neuroprotection studies have reported DSIP’s influence on oxidative stress markers in neural tissue models, generating interest in whether this neuropeptide has a broader role in supporting neuronal resilience under challenging conditions. Pain and withdrawal research has produced pre-clinical data suggesting DSIP may influence stress-related physiological responses in dependency models, reflecting its broad distribution across neuroendocrine tissues and its modulatory role in multiple stress-response systems. Its wide tissue distribution and multi-system biological presence have consistently positioned DSIP as a versatile research tool for neuroscience laboratories studying the intersection of sleep, stress, and neuroendocrine regulation.
| Parameter | Specification |
|---|---|
| Full Name | Delta Sleep-Inducing Peptide (DSIP) |
| Length | 9 Amino Acids (Nonapeptide) |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Discovery | Monnier & Schoenenberger, 1974 |
| Purity | ≥99% (HPLC & MS Verified) |
| Form | Sterile Lyophilised Powder |
| Solubility | Sterile water, bacteriostatic water |
| Storage (powder) | -20°C, protect from light |
| Storage (reconstituted) | 2–8°C, use within 2–4 weeks |
Every order of DSIP dispatched to the UAE and GCC includes:
Can I buy DSIP peptide in the UAE?
Yes. We supply research-grade DSIP with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.
How was DSIP discovered?
DSIP was first isolated in 1974 by Swiss researchers Marcel Monnier and colleagues at the University of Basel. They observed that blood taken from rabbits during slow-wave sleep could induce sleep when transferred to awake rabbits, and subsequently isolated and characterised the nonapeptide responsible for this effect — naming it Delta Sleep-Inducing Peptide after the delta waves characteristic of slow-wave sleep on EEG recordings.
Why is DSIP studied in more than just sleep research?
Although DSIP was originally identified in the context of sleep regulation, subsequent research revealed it is widely distributed throughout the brain, peripheral nervous system, pituitary gland, and various peripheral tissues — including the gut and adrenal glands. This broad tissue distribution, combined with its documented influence on multiple hormone systems and stress pathways, has made DSIP relevant to a much wider range of neuroscience and endocrinology research than sleep biology alone.
What is the connection between DSIP and the HPA axis?
The hypothalamic-pituitary-adrenal (HPA) axis is the primary stress response system — governing the release of cortisol and other stress hormones in response to physiological and psychological stressors. Research has examined how DSIP modulates HPA axis activity in pre-clinical models, exploring whether this sleep-associated neuropeptide influences stress hormone dynamics and whether there is a mechanistic link between sleep regulation and stress system modulation at the neuropeptide level.
What purity is required for DSIP neuroscience research?
A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for sensitive neurological assays, hormone measurement studies, and sleep-related pre-clinical experiments where compound purity directly affects result accuracy. All our DSIP is independently verified to ≥99% purity.
How is DSIP reconstituted for laboratory use?
Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. Aliquot immediately if longer-term storage at -80°C is required to preserve peptide integrity and avoid freeze-thaw degradation across multiple experimental uses.
How quickly is DSIP delivered to UAE?
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.
Research Disclaimer: DSIP (Delta Sleep-Inducing Peptide) is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings with appropriate institutional authorisations in place. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.
Receive News
